Some research suggests that cytoplasmic IRF3 interacts with IKKβ, inhibiting NF-κB activation, and that reduced IRF3 levels may protect hepatocytes from HFD-induced hepatic steatosis, inflammation, and macrophage infiltration (96). This evidence concerns the gene IRF3 and fatty liver disease.